Efficacy of Secukinumab in the Treatment of Moderate to Severe Plaque Psoriasis in the North American Subgroup of Patients: Pooled Analysis of Four Phase 3 Studies

David Pariser; Ellen Frankel; Joel Schlessinger; Yves Poulin; Ronald Vender; Richard G. Langley; Xiangyi Meng; Adriana Guana; Judit Nyirady

doi:10.1007/s13555-017-0211-4

Efficacy of Secukinumab in the Treatment of Moderate to Severe Plaque Psoriasis in the North American Subgroup of Patients: Pooled Analysis of Four Phase 3 Studies

David Pariser, Ellen Frankel, Joel Schlessinger, Yves Poulin, Ronald Vender, Richard G. Langley, Xiangyi Meng, Adriana Guana, Judit Nyirady

Inernational Relations Division

Research output: Contribution to journal › Article › peer-review

20 Citations (Scopus)

Original language	English
Pages (from-to)	17-32
Number of pages	16
Journal	Dermatology and Therapy
Volume	8
Issue number	1
DOIs	https://doi.org/10.1007/s13555-017-0211-4
Publication status	Published - Mar 1 2018

ASJC Scopus Subject Areas

Dermatology

Keywords

Clear or almost clear skin
Clinical trial
North America
Patient-reported outcomes
Pooled
Psoriasis
Quality of life
Secukinumab

Access to Document

10.1007/s13555-017-0211-4

Cite this

Pariser, D., Frankel, E., Schlessinger, J., Poulin, Y., Vender, R., Langley, R. G., Meng, X., Guana, A., & Nyirady, J. (2018). Efficacy of Secukinumab in the Treatment of Moderate to Severe Plaque Psoriasis in the North American Subgroup of Patients: Pooled Analysis of Four Phase 3 Studies. Dermatology and Therapy, 8(1), 17-32. https://doi.org/10.1007/s13555-017-0211-4

Pariser, D, Frankel, E, Schlessinger, J, Poulin, Y, Vender, R, Langley, RG, Meng, X, Guana, A & Nyirady, J 2018, 'Efficacy of Secukinumab in the Treatment of Moderate to Severe Plaque Psoriasis in the North American Subgroup of Patients: Pooled Analysis of Four Phase 3 Studies', Dermatology and Therapy, vol. 8, no. 1, pp. 17-32. https://doi.org/10.1007/s13555-017-0211-4

@article{6a5d484e03434094a1978cc8e664d7e0,

title = "Efficacy of Secukinumab in the Treatment of Moderate to Severe Plaque Psoriasis in the North American Subgroup of Patients: Pooled Analysis of Four Phase 3 Studies",

keywords = "Clear or almost clear skin, Clinical trial, North America, Patient-reported outcomes, Pooled, Psoriasis, Quality of life, Secukinumab",

author = "David Pariser and Ellen Frankel and Joel Schlessinger and Yves Poulin and Ronald Vender and Langley, {Richard G.} and Xiangyi Meng and Adriana Guana and Judit Nyirady",

note = "Publisher Copyright: {\textcopyright} 2017, The Author(s).",

year = "2018",

month = mar,

day = "1",

doi = "10.1007/s13555-017-0211-4",

language = "English",

volume = "8",

pages = "17--32",

journal = "Dermatology and Therapy",

issn = "2193-8210",

publisher = "Springer Verlag",

number = "1",

}

TY - JOUR

T1 - Efficacy of Secukinumab in the Treatment of Moderate to Severe Plaque Psoriasis in the North American Subgroup of Patients

T2 - Pooled Analysis of Four Phase 3 Studies

AU - Pariser, David

AU - Frankel, Ellen

AU - Schlessinger, Joel

AU - Poulin, Yves

AU - Vender, Ronald

AU - Langley, Richard G.

AU - Meng, Xiangyi

AU - Guana, Adriana

AU - Nyirady, Judit

PY - 2018/3/1

Y1 - 2018/3/1

KW - Clear or almost clear skin

KW - Clinical trial

KW - North America

KW - Patient-reported outcomes

KW - Pooled

KW - Psoriasis

KW - Quality of life

KW - Secukinumab

UR - http://www.scopus.com/inward/record.url?scp=85042478639&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85042478639&partnerID=8YFLogxK

U2 - 10.1007/s13555-017-0211-4

DO - 10.1007/s13555-017-0211-4

M3 - Article

AN - SCOPUS:85042478639

SN - 2193-8210

VL - 8

SP - 17

EP - 32

JO - Dermatology and Therapy

JF - Dermatology and Therapy

IS - 1

ER -

Efficacy of Secukinumab in the Treatment of Moderate to Severe Plaque Psoriasis in the North American Subgroup of Patients: Pooled Analysis of Four Phase 3 Studies

ASJC Scopus Subject Areas

Keywords

Access to Document

Other files and links

Fingerprint

Cite this